A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1681
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DA
Long Form : dopaminergic
No. Year Title Co-occurring Abbreviation
2020 123I-Iofluopane Single-Photon Emission Computed Tomography as an Imaging Biomarker of Pre-Synaptic Dopaminergic System after Moderate-to-Severe Traumatic Brain Injury. DAT, MP, SBR, SD, SPECT, TBI
2020 Amisulpride and l-DOPA modulate subcortical brain nuclei connectivity in resting-state pharmacologic magnetic resonance imaging. FC, VTA
2020 An In Vitro Partial Lesion Model of Differentiated Human Mesencephalic Neurons: Effect of Pericyte Secretome on Phenotypic Markers. LUHMES, PD, PDGF-BB
2020 Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling. CREB, ER, PD, PLA2G6, UPR
2020 Baicalin Represses C/EBPbeta via Its Antioxidative Effect in Parkinson's Disease. alpha-Syn, GO, LB, MPTP, PD, ROS, SN
2020 Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. PD, SN
2020 Circulating Triglycerides Gate Dopamine-Associated Behaviors through DRD2-Expressing Neurons. LPL, MCL, TGs
2020 CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. CNTNAP4, CSF, ELISAs, PD, SN
2020 Cocaine self-administration abolishes endocannabinoid-mediated long-term depression of glutamatergic synapses in the ventral tegmental area. eCB, LTD, VTA
10  2020 Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats. DREADDs
11  2020 Crocin Reverses Depression-Like Behavior in Parkinson Disease Mice via VTA-mPFC Pathway. FST, mPFC, MPTP, mTOR, PD, PDD, VTA
12  2020 Curcumin-Activated Mesenchymal Stem Cells Derived from Human Umbilical Cord and Their Effects on MPTP-Mouse Model of Parkinson's Disease: A New Biological Therapy for Parkinson's Disease. CM-CUR, hUC-MSCs-CUR, MAP2, PD, TH
13  2020 Differential Expression of microRNA Profiles and Wnt Signals in Stem Cell-Derived Exosomes During Dopaminergic Neuron Differentiation. EpiSCs, ESCs, miRNAs, TH
14  2020 Direct Reprogramming of Human Fetal- and Stem Cell-Derived Glial Progenitor Cells into Midbrain Dopaminergic Neurons. hGPCs
15  2020 Does altering proteasomal activity and trafficking reduce the arborization mediated specific vulnerability of SNpc dopaminergic neurons of Parkinson's disease? PD, SNpc, VTA
16  2020 Dopaminergic modulation of olfactory-evoked motor output in sea lampreys (Petromyzon marinus L.). OB
17  2020 Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders. APO, CLO, GH, NA, PRL
18  2020 Dose-dependent effects of estrogen on prediction error related neural activity in the nucleus accumbens of healthy young women. NAc, PE
19  2020 Downregulation of eEF1A/EFT3-4 Enhances Dopaminergic Neurodegeneration After 6-OHDA Exposure in C. elegans Model. 6-OHDA, mTOR, PD, PI3K, RNAi
20  2020 Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson's disease model via a beta-arrestin2-biased mechanism. DRD2, IL-1beta, MPTP, PD
21  2020 Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1beta signaling pathway in MPTP-induced Parkinson's disease model. CASP, ECH, IL-1beta, MPTP, NLRP3, PD, SN, TH
22  2020 Effect of Wenshen-Yanggan Decoction on Movement Disorder and Substantia Nigra Dopaminergic Neurons in Mice with Chronic Parkinson's Disease. Bcl-2, ELISA, p-JNK, PD, TH
23  2020 Effects of brief inhibition of the ventral tegmental area dopamine neurons on the cocaine seeking during abstinence. CS, TH, VTA
24  2020 Effects on Dopaminergic Neurons Are Secondary in COX-Deficient Locomotor Dysfunction in Drosophila. COX
25  2020 Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction. DOPAL, PD
26  2020 Emergence of novel functions in striatal low-threshold spike interneurons (Commentary on Gazan et al., 2019). GLU, SPNs, top
27  2020 Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N. iPSC, PD, VPS35
28  2020 Enhanced Hyaluronan Signaling and Autophagy Dysfunction by VPS35 D620N. ECM, HA, HMMR, PD, RNA-Seq
29  2020 Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease. AD, FGF21, PD, SN
30  2020 Functional dopaminergic neurons derived from human chorionic mesenchymal stem cells ameliorate striatal atrophy and improve behavioral deficits in Parkinsonian rat model. HCMSCs, PD
31  2020 Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra. AAVs, GFAP, GLT-1, PD, PSD-95, shRNA, siRNAs, SNpc
32  2020 Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN(p. C253Y). iPSC, PD
33  2020 Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice. Grx1, PD, SNpc
34  2020 Heterogeneous expression of dopaminergic markers and Vglut2 in mouse mesodiencephalic dopaminergic nuclei A8-A13. DAT, TH, VGLUT2
35  2020 Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria. ACM, PD
36  2020 Identification of a molecular basis for the juvenile sleep state. ---
37  2020 In silico Hierarchical Clustering of Neuronal Populations in the Rat Ventral Tegmental Area Based on Extracellular Electrophysiological Properties. AP, CV, VTA
38  2020 In Vivo Assessment of Cell Death and Nigrostriatal Pathway Integrity Following Continuous Expression of C3 Transferase. AAV, EYFP, PD, SNc, TH
39  2020 Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of alpha-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling. IR, PD, PGC, PLK2, ROS, SNCA
40  2020 Investigating the influence of perinatal nicotine and alcohol exposure on the genetic profiles of dopaminergic neurons in the VTA using miRNA-mRNA analysis. VTA
41  2020 Involvement of MEK5/ERK5 signaling pathway in manganese-induced cell injury in dopaminergic MN9D cells. ERK5, IPD, MEK5, Mn, ROS
42  2020 Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinsons Disease. CREB, GCM-LGF, LGF, MAPKs, SN, TNF-alpha
43  2020 Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease. CREB, FMRP, FXS, ILBD, MMP9, PD, PKC, SNc
44  2020 Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice. EOPD, PD
45  2020 MES23.5 DA Immortalized Neuroblastoma Cells Self-protect Against Early Injury by Overexpressing Glial Cell-derived Neurotrophic Factor via Akt1/Eya1/Six2 Signaling. Eya, GDNF, Six2
46  2020 Metabolic alterations in Parkinson's disease astrocytes. PD
47  2020 Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells. hPSCs, PD, scRNA-seq
48  2020 miR-7 Controls the Dopaminergic/Oligodendroglial Fate through Wnt/beta-catenin Signaling Regulation. ---
49  2020 Mitochondrial Homeostasis and Signaling in Parkinson's Disease. PD
50  2020 Nei-like 1 inhibition results in motor dysfunction and promotes inflammation in Parkinson's disease mice model. DAT, GFAP, Iba-1, MPTP, NEIL1, PD, TH
51  2020 Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. nAChRs
52  2020 Neurochemical and neuroinflammatory perturbations in two Gulf War Illness models: Modulation by the immunotherapeutic LNFPIII. CORT, DEET, DFP, GW, GWI, LNFPIII, PB, PM
53  2020 Neuronal activity triggers uptake of hematopoietic extracellular vesicles in vivo. EVs
54  2020 NF-kappaB-Mediated Neuroinflammation in Parkinson's Disease and Potential Therapeutic Effect of Polyphenols. NF-kappaB, PD
55  2020 NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin. IL-1 beta, NLRP3, PD
56  2020 Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. ---
57  2020 Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase. CNS, PD, PGK, ROS
58  2020 Olfactory ensheathing cells improve the survival of porcine neural xenografts in a Parkinsonian rat model. hfVM, OECs, PD, pfVM
59  2020 Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts. PD
60  2020 Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review. PD, SNpc, TCM
61  2020 Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells. HDs, iPSCs, NTFs, PD, SN, TDNs
62  2020 Pathogenic insights to Parkin-linked model mice. PD
63  2020 Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons. PD, SAPNS
64  2020 PERK-Mediated eIF2alpha Phosphorylation Contributes to The Protection of Dopaminergic Neurons from Chronic Heat Stress in Drosophila. ER, PD, UPR
65  2020 PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila. PD
66  2020 Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease. MPTP, MWM, PD, SNpc
67  2020 Polyphenols from Toona sinensiss Seeds Alleviate Neuroinflammation Induced by 6-Hydroxydopamine Through Suppressing p38 MAPK Signaling Pathway in a Rat Model of Parkinson's Disease. CCK-8, COX-2, iNOS, PTSS, SD, TNF-alpha
68  2020 Postnatal functional inactivation of the ventral subiculum enhances dopaminergic responses in the core part of the nucleus accumbens following ketamine injection in adult rats. NAcc, PND8, SUB, TTX
69  2020 Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease. DAPs, iPSC, PD
70  2020 Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease. iPSCs, PD
71  2020 Prenatal Ethanol Exposure and Postnatal Environmental Intervention Alter Dopaminergic Neuron and Microglia Morphology in the Ventral Tegmental Area During Adulthood. PE, VTA
72  2020 Pro-survival and anti-inflammatory roles of NF-kappaB c-Rel in the Parkinson's disease models. NF-kappaB, PD, SNpc
73  2020 Protective Effect of Fucoidan against MPP+-Induced SH-SY5Y Cells Apoptosis by Affecting the PI3K/Akt Pathway. PD
74  2020 Protective effect of hydroxysafflor yellow A on dopaminergic neurons against 6-hydroxydopamine, activating anti-apoptotic and anti-neuroinflammatory pathways. APO, HSYA, IHC, PD, SN, STR, TH
75  2020 Protective effect of metformin against rotenone-induced parkinsonism in mice. ER, PD, SN
76  2020 Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. HFD, LPS, ROT
77  2020 Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons. AAV, PD, VM
78  2020 Reduced Dpp expression accelerates inflammation-mediated neurodegeneration through activated glial cells during altered innate immune response in Drosophila. Dpp, PD, PQ, TGF-beta, WT
79  2020 Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP+ -induced model of Parkinson's disease. MEF2D, MPTP, ND6, PD, Sal
80  2020 The onjisaponin B metabolite tenuifolin ameliorates dopaminergic neurodegeneration in a mouse model of Parkinson's disease. IL-1beta, IL-6, MPTP, OB, PD
81  2020 The Potential Role of Astrocytes in Parkinson's Disease (PD). ALS, AQP4, EAATs, GABA, ND, PD, SNpc, STN
82  2020 Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson's Disease and Diabetes. CCCP, HG, PD, ROS, TXNIP
83  2020 Vascular endothelial growth factor-loaded poly-lactic-co-glycolic acid nanoparticles with controlled release protect the dopaminergic neurons in Parkinson's rats. NS, VEGF
84  2020 Zonisamide promotes survival of human-induced pluripotent stem cell-derived dopaminergic neurons in the striatum of female rats. iPS, SLITRK6, ZNS
85  2019 A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration. BMP, Gbb, LRRK2, pMad
86  2019 A test of dopamine hyper- and hyposensitivity in alcohol use. FRN
87  2019 AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson's disease. alpha-syn-WT, GFP, PD, SNpc
88  2019 Activation of Peroxisome Proliferator-Activated Receptor-alpha Increases the Expression of Nuclear Receptor Related 1 Protein (Nurr1) in Dopaminergic Neurons. Nurr1, PD, PPAR
89  2019 Acute Tramadol-Induced Cellular Tolerance and Dependence of Ventral Tegmental Area Dopaminergic Neurons: An In Vivo Electrophysiological Study. VTA
90  2019 Age-Associated Dopaminergic Neuron Loss and Midbrain Glia Cell Phenotypic Polarization. Arg1, BDNF, GDNF, IL-1beta, Lcn2, TNF-alpha
91  2019 Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity. alpha-Syn, ClpP, PD, SOD2
92  2019 Alterations and adaptation of ventral tegmental area dopaminergic neurons in animal models of depression. VTA
93  2019 Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism. DA1, DMV, PD
94  2019 AMP Kinase Activation is Selectively Disrupted in the Ventral Midbrain of Mice Deficient in Parkin or PINK1 Expression. AMPK, pAMPK, PD, SNpc
95  2019 Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota. AQ, BU, BW, CT, EA, ET, PD
96  2019 Anticancer Drugs for Parkinson's Disease: Is It a Ray of Hope or Only Hype? PD
97  2019 Astrocyte-Like Cells Differentiated from Dental Pulp Stem Cells Protect Dopaminergic Neurons Against 6-Hydroxydopamine Toxicity. DPSCs, GFAP, NO
98  2019 Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus. AREs, hPSCs, PD, PKC, SN
99  2019 Biochanin A protects against angiotensin II-induced damage of dopaminergic neurons in rats associated with the increased endophilin A2 expression. Ang II, AT1R, EPA2, GPCR
100  2019 Catalpol Exerts a Neuroprotective Effect in the MPTP Mouse Model of Parkinson's Disease. GAP43, MPTP, PD, TH, VEGF